Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol. 2019;25(1):42-51.   Published online 2018 Nov 19     DOI: https://doi.org/10.3350/cmh.2018.0029
Citations to this article as recorded by Crossref logo
Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
Young Woo Eom, Soon Koo Baik
Clinical and Molecular Hepatology.2019; 25(1): 37.     CrossRef